09969.HK
InnoCare Pharma Limited
HKSE · Healthcare · Biotechnology · CN
HKD 15.37
+4.06%Next report
Analyst consensus
- Next report date
- Nov 16, 2026
- EPS estimate
- —
- Revenue estimate
- HKD 690.6M
Latest reported
- Last report date
- Aug 24, 2026
- EPS actual
- HKD 0.09
- EPS estimate
- —
- Revenue actual
- HKD 702.0M
- Revenue estimate
- HKD 805.3M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- 0
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 16, 2026